Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
Category: Blood Cancers
Evading exhaustion to improve CAR-T cell therapy
'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.
In the Spotlight: From Sesame Street to Stanford
In this In the Spotlight, hematologist/oncologist Gabriel Mannis talks about his passion for medicine and his experience working at Sesame Street.
Immunotherapy target identified for pediatric cancers
Stanford scientists have moved a big step closer toward using engineered immune cells to treat many forms of pediatric cancer.
Trying to get answers: One woman’s quest for a diagnosis
After a year of baffling symptoms, two Stanford specialists pieced together the puzzle of this woman's disease.
Tumor cells’ ‘tells’ may allow some cancer patients to dodge unnecessary chemotherapy
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
New method could predict leukemia relapse at diagnosis
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
“A very hopeful job”– saving the sickest kids with a new leukemia therapy
As a parent, some stories are more difficult to write than others. My recent Stanford Medicine magazine article about kids with leukemia is an example. …
New target for CAR T cell leukemia therapy “gives hope” to researchers at Stanford, NCI
Last August, a new leukemia therapy called CAR T-cells burst onto the national stage when it was approved by the Food and Drug Administration to …
New blood cancer treatment gets FDA approval
More than 20 years ago, for a high school science project, I gave a presentation to my biology class on gene therapy. To me, the …
From a single patient to a global clinical trial: One hematologist’s journey
Confronted in 2002 by a medical record that was literally two feet in height, Stanford hematologist Jason Gotlib, MD, had no idea that his career path …
Resetting leukemia cells
The question sounds more like sociology than biology: What would happen if you could take a cell gone bad -- a cancer cell -- bring …
Drug combinations that help breast cancer patients discovered using data science
When computer scientist Andrew A. Radin came to Stanford University School of Medicine and enrolled in a biomedical informatics course, he was just there to …
New Stanford-developed tool allows easier study of blood cancers
In the history of science and medicine, the breakthrough discoveries get a lot of deserved attention, but often overlooked are the invention of the tools …
The mysterious story of a boy who survived a rare and deadly cancer
What would you do if your toddler had a very rare blood cancer and his treatments were failing? At what point would you decide that …
Nowhere to hide: Blood-based cancer monitoring gets ever more sensitive
A quick update on a fascinating advance in cancer detection that I've written about before, which is the increasing ability of researchers to detect …